IRIS
RIA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.635
AS - Asia 6.106
EU - Europa 5.371
SA - Sud America 1.452
Continente sconosciuto - Info sul continente non disponibili 743
AF - Africa 260
OC - Oceania 14
Totale 29.581
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.345
SG - Singapore 2.509
IT - Italia 1.765
CN - Cina 1.365
BR - Brasile 1.163
SE - Svezia 805
HK - Hong Kong 720
RU - Federazione Russa 559
DE - Germania 545
VN - Vietnam 411
FR - Francia 354
FI - Finlandia 335
GB - Regno Unito 317
UA - Ucraina 274
BD - Bangladesh 272
IN - India 205
CA - Canada 139
AR - Argentina 94
ID - Indonesia 91
JP - Giappone 74
MX - Messico 73
IQ - Iraq 70
BE - Belgio 63
NL - Olanda 62
CO - Colombia 61
ZA - Sudafrica 60
CI - Costa d'Avorio 59
TR - Turchia 53
PK - Pakistan 51
IE - Irlanda 46
SA - Arabia Saudita 44
PH - Filippine 42
PL - Polonia 42
VE - Venezuela 42
ES - Italia 41
UZ - Uzbekistan 38
AT - Austria 33
EC - Ecuador 33
CZ - Repubblica Ceca 31
MA - Marocco 29
LT - Lituania 27
MY - Malesia 21
TN - Tunisia 20
AE - Emirati Arabi Uniti 19
EG - Egitto 19
KE - Kenya 19
JO - Giordania 18
PE - Perù 17
JM - Giamaica 13
TT - Trinidad e Tobago 13
AU - Australia 12
UY - Uruguay 12
CL - Cile 11
PY - Paraguay 10
AL - Albania 9
IR - Iran 9
KR - Corea 9
RO - Romania 9
RS - Serbia 9
AZ - Azerbaigian 8
NP - Nepal 8
PA - Panama 8
PT - Portogallo 8
CR - Costa Rica 7
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
LB - Libano 7
OM - Oman 7
TH - Thailandia 7
BO - Bolivia 6
CH - Svizzera 6
HN - Honduras 6
KW - Kuwait 6
PS - Palestinian Territory 6
SV - El Salvador 6
DO - Repubblica Dominicana 5
GR - Grecia 5
GT - Guatemala 5
KZ - Kazakistan 5
MK - Macedonia 5
HT - Haiti 4
NO - Norvegia 4
QA - Qatar 4
SN - Senegal 4
TW - Taiwan 4
AO - Angola 3
CG - Congo 3
HU - Ungheria 3
LY - Libia 3
NG - Nigeria 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BF - Burkina Faso 2
BH - Bahrain 2
CV - Capo Verde 2
CY - Cipro 2
EU - Europa 2
GE - Georgia 2
GH - Ghana 2
Totale 28.786
Salva come PNG Salva come JPEG
Città #
Ashburn 1.602
Fairfield 1.541
Singapore 1.360
Chandler 1.130
San Jose 1.089
Woodbridge 1.071
Hong Kong 693
Houston 679
Seattle 646
Nyköping 595
Jacksonville 585
Milan 577
Cambridge 561
Wilmington 509
Ann Arbor 482
Beijing 413
Council Bluffs 348
New York 347
Los Angeles 252
Lawrence 213
Lauterbourg 212
Roxbury 212
Rome 209
Nanjing 204
Dallas 185
Bari 181
Helsinki 169
Des Moines 135
Munich 130
Ho Chi Minh City 122
Boardman 117
Santa Clara 113
Inglewood 111
Princeton 106
São Paulo 99
Buffalo 93
Columbus 93
Brooklyn 84
Chicago 72
Hanoi 69
London 68
San Diego 65
Brussels 61
Abidjan 59
Falkenstein 58
Nanchang 57
Jakarta 52
Shenyang 52
Frankfurt am Main 50
Tokyo 50
Figino 48
Montreal 46
Turin 45
Dublin 44
Moscow 44
Dearborn 42
Denver 41
Dong Ket 40
Jiaxing 38
Orem 36
Phoenix 36
The Dalles 36
Baghdad 35
Tashkent 35
Toronto 34
Stockholm 33
Hebei 31
Chennai 30
Nuremberg 30
Pune 30
Brno 28
Johannesburg 28
Marseille 28
San Francisco 28
Atlanta 27
Leawood 27
Naples 27
Tianjin 26
Paris 25
Washington 25
Guangzhou 24
Mexico City 24
Amsterdam 23
Belo Horizonte 23
Turku 23
Warsaw 23
Florence 22
Brasília 21
Curitiba 21
Changsha 20
Dhaka 20
Grafing 20
Haiphong 20
Poplar 20
Rio de Janeiro 20
Salt Lake City 20
Augusta 19
Manchester 19
Tampa 19
Bogotá 18
Totale 19.423
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 303
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 252
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 225
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 221
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 209
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 199
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 196
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 194
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 194
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 192
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 190
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 189
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 188
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 186
Identify multiple myeloma stem cells: Utopia? 186
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 185
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 184
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 181
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 178
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 177
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis 175
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 174
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 172
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 171
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 171
Neutropenia and G-CSF in lymphoproliferative diseases 168
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 167
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 162
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 161
Bortezomib treatment modulates autophagy in multiple myeloma 161
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 160
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 159
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 158
90y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell trasplantation in aggressive non-Hodgkin lymphoma 157
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 156
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 155
Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers? 151
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 151
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response 150
Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials 150
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 149
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents 148
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials 148
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 148
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 146
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 145
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 145
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. 144
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 144
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? 143
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 142
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 142
Could multiple myeloma VEGF modify the systemic microcirculation? 141
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 140
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts 139
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients 139
Endothelial cells in the bone marrow of patients with multiple myeloma 139
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma 139
A Challenging Case of Visceral Leishmaniasis 138
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 138
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma 137
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis 137
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 136
A weekly infusion of bortezomib reduces peripheral neuropathy 136
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 135
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 134
Angiogenesis and Antiangiogenesis in Multiple Myeloma 134
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 134
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 133
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 132
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma 132
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas 132
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 131
Vascular Endothelial Growth Factor and its Receptors in Multiple Myeloma 130
Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia 130
HIF-1a of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target 130
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial 129
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 129
Circulating cell adhesion molecules are increased in hypertensive left ventricular hypertrophy 128
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression 127
An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis 127
Circulating miRNA markers show promise as new prognosticators for multiple myeloma 126
Fibrinogen apheresis in the treatment of peripheral arterial disease 124
Delayed complete remission in a patient with multiple myeloma 124
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 124
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial 123
Mast cell contribution to angiogenesis related to tumour progression 123
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma 123
Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? 121
Efficacy of filgrastim, lenograstim and peg-filgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative disorders. 121
Angiogenesis in multiple myeloma 121
Novel agents and new therapeutic approaches for treatment of multiple myeloma 120
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 120
Angiogenesi e progressione tumorale nel melanoma 119
Efficacy and safety of once weekly bortezomib in multiple myeloma patients 119
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 118
Effects of severe hypertension on soluble cellular adhesion molecule levels 118
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma 117
A VEGF-dependent autocrine loop on endothelial cells pomotes angiogenesis and progression in multiple myeloma 116
TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically 116
Totale 15.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.284 0 0 17 52 63 106 92 84 95 122 272 381
2022/20232.859 377 297 182 277 328 420 21 302 524 22 52 57
2023/20241.174 99 196 71 60 104 327 60 71 7 21 28 130
2024/20254.456 126 96 319 204 122 409 421 429 185 271 686 1.188
2025/20269.853 1.381 401 525 972 1.079 588 1.045 309 1.126 893 415 1.119
2026/20271.236 339 534 363 0 0 0 0 0 0 0 0 0
Totale 29.581